Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|March 6, 2025
LPS-enriched interaction drives spectrum conversion in antimicrobial peptides: Design and optimization of AA16 derivatives for targeting gram-negative bacteriaWanyang Xiao, Ruize Sun, Jietao Lou, et al.
Frontiers in Behavioral Neuroscience|January 11, 2020
The Neuro Patterns Prior to Error Responses in Long-Lasting Working Memory Task: An Event-Related Potential StudyYi Xiao, Jintao Wu, Jiaxuan Li, et al.
Journal of Medicinal Chemistry|June 12, 2026
Design, Synthesis, and Biological Evaluation of a MyD88-Targeted Molecular Glue d21 for the Treatment of Acute Lung InjuryLuxiao Zhu, Dan Tang, Ting Chen, et al.
Frontiers in Psychiatry|June 1, 2026
A hierarchical machine learning model for predicting self-harm and suicidal behaviour in hospitalised patients with schizophrenia using clinical history and nursing observationsChen Liang, Xianfeng Meng, Ying Duan, et al.
Frontiers in Psychiatry|October 8, 2025
Hierarchical machine learning model integrating clinical history and nursing observations for predicting violent behavior in hospitalized schizophrenia patientsXianfeng Meng, Liang Wang, Ying Duan, et al.
Journal of Medicinal Chemistry|September 12, 2025
Discovery of <b>3g</b> as an Orally Bioavailable, TIR Domain Selective, and Potent MyD88 Inhibitor for the Treatment of Acute Lung InjuryPan Chen, Ke Dong, Luxiao Zhu, et al.
Journal of Medicinal Chemistry|June 24, 2024
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung InjuryYu Zou, Xiemin Wang, Pan Chen, et al.
European Journal of Medicinal Chemistry|February 29, 2024
Discovery of novel osthole derivatives exerting anti-inflammatory effect on DSS-induced ulcerative colitis and LPS-induced acute lung injury in miceYing Zhou, Zhiteng Du, Qianqian Wu, et al.
European Journal of Medicinal Chemistry|March 4, 2025
Anti-inflammatory agents design via the fragment hybrid strategy in the discovery of compound c1 for treating ALI and UCMi Guo, Yu Zou, Ke Dong, et al.
Journal of Medicinal Chemistry|February 23, 2026
Discovery of <b>6l</b> with a New Skeleton of 6-Oxo-<i>N</i>-(4-(Quinolin-4-yloxy)phenyl)-1,6-dihydropyridine-3-carboxamide as a Dual-Action Inhibitor against JNK2 and the MKK7-JNK2 Protein-Protein Interaction for Acute Lung InjuryQi Chen, Ke Dong, Yaping Zhan, et al.
Pageof 3